These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 29253594

  • 41. The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection.
    Wang Y, Bai Y, Qu Q, Xu J, Chen Y, Zhong Z, Qiu Y, Wang T, Du X, Wang Z, Yu S, Fu S, Yuan J, Zhen Q, Yu Y, Chen Z, Huang L.
    Vet Microbiol; 2011 Aug 05; 151(3-4):354-62. PubMed ID: 21530111
    [Abstract] [Full Text] [Related]

  • 42. A comparison between adjuvant and delivering functions of calcium phosphate, aluminum hydroxide and chitosan nanoparticles, using a model protein of Brucella melitensis Omp31.
    Abkar M, Alamian S, Sattarahmady N.
    Immunol Lett; 2019 Mar 05; 207():28-35. PubMed ID: 30707922
    [Abstract] [Full Text] [Related]

  • 43. Evaluation of immunogenicity of novel multi-epitope subunit vaccines in combination with poly I:C against Brucella melitensis and Brucella abortus infection.
    Sadeghi Z, Fasihi-Ramandi M, Bouzari S.
    Int Immunopharmacol; 2019 Oct 05; 75():105829. PubMed ID: 31437796
    [Abstract] [Full Text] [Related]

  • 44. Protective effect of a DNA vaccine containing an open reading frame with homology to an ABC-type transporter present in the genomic island 3 of Brucella abortus in BALB/c mice.
    Riquelme-Neira R, Retamal-Díaz A, Acuña F, Riquelme P, Rivera A, Sáez D, Oñate A.
    Vaccine; 2013 Aug 12; 31(36):3663-7. PubMed ID: 23834811
    [Abstract] [Full Text] [Related]

  • 45. Immunogenicity of the Brucella melitensis recombinant ribosome recycling factor-homologous protein and its cDNA.
    Cassataro J, Velikovsky CA, Giambartolomei GH, Estein S, Bruno L, Cloeckaert A, Bowden RA, Spitz M, Fossati CA.
    Vaccine; 2002 Feb 22; 20(11-12):1660-9. PubMed ID: 11858876
    [Abstract] [Full Text] [Related]

  • 46. Construction of recombinant Omp25 or EipB protein loaded PLGA nanovaccines for Brucellosis protection.
    Akmayan I, Oztav S, Coksu I, Abamor ES, Acar S, Ozbek T.
    Nanotechnology; 2024 Jul 12; 35(39):. PubMed ID: 38917779
    [Abstract] [Full Text] [Related]

  • 47. Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections.
    Abkar M, Amani J, Sahebghadam Lotfi A, Nikbakht Brujeni G, Alamian S, Kamali M.
    APMIS; 2015 Aug 12; 123(8):667-75. PubMed ID: 25939375
    [Abstract] [Full Text] [Related]

  • 48. Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant.
    Li Z, Wang S, Zhang H, Xi L, Zhang J, Zhang X, Zhou Q, Yi J, Li M, Zhang W, Zhang J.
    Microb Pathog; 2018 Nov 12; 124():250-257. PubMed ID: 30149131
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Invasive Escherichia coli vaccines expressing Brucella melitensis outer membrane proteins 31 or 16 or periplasmic protein BP26 confer protection in mice challenged with B. melitensis.
    Gupta VK, Radhakrishnan G, Harms J, Splitter G.
    Vaccine; 2012 Jun 08; 30(27):4017-22. PubMed ID: 22546330
    [Abstract] [Full Text] [Related]

  • 52. Nanoparticle or conventional adjuvants: which one improves immune response against Brucellosis?
    Yousefi S, Abbassi-Daloii T, Tahmoorespur M, Sekhavati MH.
    Iran J Basic Med Sci; 2019 Apr 08; 22(4):360-366. PubMed ID: 31168339
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice.
    Velikovsky CA, Cassataro J, Giambartolomei GH, Goldbaum FA, Estein S, Bowden RA, Bruno L, Fossati CA, Spitz M.
    Infect Immun; 2002 May 08; 70(5):2507-11. PubMed ID: 11953389
    [Abstract] [Full Text] [Related]

  • 56. Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosis.
    Lindler LE, Hadfield TL, Tall BD, Snellings NJ, Rubin FA, Van De Verg LL, Hoover D, Warren RL.
    Infect Immun; 1996 Jul 08; 64(7):2490-9. PubMed ID: 8698471
    [Abstract] [Full Text] [Related]

  • 57. Induction of protective immunity against brucellosis in mice by vaccination with a combination of naloxone, alum, and heat-killed Brucella melitensis 16 M.
    Motaharinia Y, Rezaee MA, Rashidi A, Jalili A, Rezaie MJ, Shapouri R, Hossieni W, Rahmani MR.
    J Microbiol Immunol Infect; 2013 Aug 08; 46(4):253-8. PubMed ID: 22727892
    [Abstract] [Full Text] [Related]

  • 58. Evaluation of the protective effect of immunization spf DBA/2J mice with selected bacterial, recombinant Hsp60 antigens during Salmonella Enteritidis challenge.
    Bajzert J, Gorczykowski M, Stefaniak T.
    Microb Pathog; 2019 Mar 08; 128():206-214. PubMed ID: 30615999
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Characterization of outer membrane vesicles from Brucella melitensis and protection induced in mice.
    Avila-Calderón ED, Lopez-Merino A, Jain N, Peralta H, López-Villegas EO, Sriranganathan N, Boyle SM, Witonsky S, Contreras-Rodríguez A.
    Clin Dev Immunol; 2012 Mar 08; 2012():352493. PubMed ID: 22242036
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.